Oct 20, 2026 · 31 min
Market breadth improves as major indexes test resistance
Major Indexes Test Resistance; Lindblad, Kiniksa Pharma, Guidewire In Focus
The episode weighs fragile index action and semiconductor weakness against emerging leadership in healthcare, biotech, energy, and select software.
- 1The Nasdaq tests its 50-day moving average while the S&P 500 nears resistance and the Dow shows relative strength.
- 2Healthcare, biotech, energy, and selected software names are improving even as semiconductor weakness raises broader AI-spending concerns.
- 3Lindblad Expeditions, Kiniksa Pharma, and Guidewire illustrate how strong individual setups can emerge in uneven market conditions.
Don't miss
The hosts compare Lindblad Expeditions’ breakout, improving profitability, and relative strength with the broader market’s uncertain conditions.
The brief
Alissa Coram and Ed Carson assess a mixed session: the Nasdaq tests its 50-day moving average, the S&P 500 nears resistance, and the Dow leads on relative strength.
Semiconductor weakness exposes doubts about AI capital spending, profitability, and financing, while upcoming mega-cap earnings could test the market’s assumptions.
Oil volatility and uneven Magnificent Seven performance contrast with improving leadership in healthcare, biotech, energy, insurers, payments, and select software.
Lindblad Expeditions, Kiniksa Pharma, and Guidewire provide three different examples of actionable strength, from an ecotourism breakout to biotech and insurance software.
SpaceX’s earnings, Netflix’s technical deterioration, and the episode’s closing focus on guidance reinforce the need to judge stocks within broader market conditions.
What was said on this episode
26 statements · 15 positive · 10 negative · 1 mixed
The Nasdaq needs to rise above resistance before market conditions improve materially.
“the NASDAQ still really needs to get above there”
Listen at 2:16
Meta raising AI capital spending 50% while reporting strong profitability could improve AI sentiment.
“if Meta comes out and says, you know, we're raising it by 50%, we are making so much money”
Listen at 4:32
Hints that AI investment is not paying off could sharply worsen market conditions.
“If they give any hint of saying, you know what? It's not really paying off that great. Then I think things get really ugly.”
Listen at 4:50
Investors should exit remaining AI positions if the sector breaks down.
“If things break down, if I have anything left in AI, I got to get out.”
Listen at 5:49
One or two strong days could materially improve the S&P 500’s technical setup.
“one good day we're clearly about we're above the 21 day line we're above that trend line we're very close to record highs”
Listen at 7:02
Removing AI financing concerns could cause Treasury yields to spike.
“if the AI financing concerns go away, one of the interesting things is, do the treasury yield spike?”
Listen at 10:25
Investors should avoid excessive concentration because violent market rotations remain possible.
“don't go full hog or get too concentrated in any particular thing”
Listen at 10:56
Nontechnology and non-AI sectors currently offer many attractive opportunities.
“you get outside of tech and really the AI space, and there's a lot to like”
Listen at 13:29
Healthcare and biotech should be core areas for investors to consider.
“definitely stuff to to be definitely a core area for investors to be looking at”
Listen at 15:43
Lindblad Expeditions is shifting to annual profitability this year.
“This is shifting into annual profitability this year.”
Listen at 17:39
Ecotourism generally attracts affluent customers.
“ecotourism tends to be an affluent audience”
Listen at 18:11
Lindblad’s affluent ecotourism customers may be resilient to inflationary pressures.
“They're probably somewhat resilient to that.”
Listen at 18:23
Lindblad Expeditions should achieve solid growth next year.
“next year should be some solid growth as well”
Listen at 19:23
Kiniksa Pharmaceuticals has strong revenue and earnings growth.
“this is clearly in the growth space. This is like strong growth, top and bottom line.”
Listen at 21:09
Kiniksa is a profitable biotech rather than a high-risk development-stage company.
“Again, a biotech with strong profitability, not, you know, development stage, which has a lot of risk”
Listen at 21:15
Guidewire Software is currently forming a potentially actionable technical setup.
“Guidewire setting up here”
Listen at 22:36
Guidewire Software has solid growth.
“this one has solid growth”
Listen at 23:23
Investors entering Guidewire should be cautious around its earnings report.
“I would definitely, so if you do get into this, watch out for that.”
Listen at 24:25
SpaceX appears to have reported its first GAAP-profitable quarter.
“it seems to be the first profitable quarter on like a gap basis. in the first ever, perhaps.”
Listen at 26:00
SpaceX’s profitability could eventually help it qualify for S&P 500 inclusion.
“eventually that will help it get into the S&P 500”
Listen at 26:07
SpaceX revenue is surging because of AI compute deals.
“Revenue surging, again, because of all these AI compute deals”
Listen at 26:14
SpaceX’s AI compute-related revenue growth will likely slow as excess capacity is sold.
“I assume that growth will slow down just because they're selling all this excess stuff.”
Listen at 26:20
Netflix’s growth is expected to slow dramatically.
“the feeling is that growth is going to slow dramatically”
Listen at 28:41
Netflix is currently struggling across many performance metrics.
“now they're really struggling, I think, on a lot of metrics”
Listen at 28:57
Investors should wait for Netflix’s fundamentals and chart to turn around before buying.
“Better to wait for an actual turnaround in the fundamentals and in the chart.”
Listen at 29:40
Intuitive Surgical’s negative earnings reaction may reflect its growth guidance.
“maybe something with the guidance, you know, how much growth they see on their surgical systems”
Listen at 30:03
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.